TSHA logo

Taysha Gene Therapies (TSHA) Operating profit

annual operating profit:

-$86.62M-$15.25M(-21.36%)
December 31, 2024

Summary

  • As of today (June 22, 2025), TSHA annual operating income is -$86.62 million, with the most recent change of -$15.25 million (-21.36%) on December 31, 2024.
  • During the last 3 years, TSHA annual operating profit has risen by +$86.65 million (+50.01%).
  • TSHA annual operating profit is now -101.43% below its all-time high of -$43.00 million, reached on December 31, 2020.

Performance

TSHA Operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTSHAincome statement metrics

quarterly operating profit:

-$21.42M-$1.49M(-7.47%)
March 31, 2025

Summary

  • As of today (June 22, 2025), TSHA quarterly operating income is -$21.42 million, with the most recent change of -$1.49 million (-7.47%) on March 31, 2025.
  • Over the past year, TSHA quarterly operating profit has increased by +$2.91 million (+11.96%).
  • TSHA quarterly operating profit is now -1821.17% below its all-time high of -$1.11 million, reached on December 1, 2019.

Performance

TSHA quarterly operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTSHAincome statement metrics

TTM operating profit:

-$83.71M+$2.91M(+3.36%)
March 31, 2025

Summary

  • As of today (June 22, 2025), TSHA TTM operating income is -$83.71 million, with the most recent change of +$2.91 million (+3.36%) on March 31, 2025.
  • Over the past year, TSHA TTM operating profit has dropped by -$4.57 million (-5.77%).
  • TSHA TTM operating profit is now -7407.80% below its all-time high of -$1.11 million, reached on December 1, 2019.

Performance

TSHA TTM operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTSHAincome statement metrics

Operating profit Formula

Operating Profit = Gross Profit − Operating Expenses

TSHA Operating profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-21.4%+12.0%-5.8%
3 y3 years+50.0%+56.9%+56.1%
5 y5 years--283.6%-1149.6%

TSHA Operating profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-21.4%+50.0%-37.0%+56.9%-17.3%+56.1%
5 y5-year-101.4%+50.0%-434.2%+57.7%-1149.6%+56.1%
alltimeall time-101.4%+50.0%-1821.2%+57.7%-7407.8%+56.1%

TSHA Operating profit History

DateAnnualQuarterlyTTM
Mar 2025
-
-$21.42M(+7.5%)
-$83.71M(-3.4%)
Dec 2024
-$86.62M(+21.4%)
-$19.93M(-5.4%)
-$86.62M(+5.0%)
Sep 2024
-
-$21.06M(-1.1%)
-$82.49M(+7.0%)
Jun 2024
-
-$21.30M(-12.5%)
-$77.06M(-2.6%)
Mar 2024
-
-$24.33M(+54.0%)
-$79.14M(+10.9%)
Dec 2023
-$71.37M(-43.4%)
-$15.80M(+1.0%)
-$71.37M(-2.4%)
Sep 2023
-
-$15.63M(-33.1%)
-$73.12M(-11.8%)
Jun 2023
-
-$23.38M(+41.2%)
-$82.95M(-10.7%)
Mar 2023
-
-$16.56M(-5.6%)
-$92.94M(-26.3%)
Dec 2022
-$126.03M
-$17.55M(-31.1%)
-$126.03M(-20.3%)
Sep 2022
-
-$25.46M(-23.7%)
-$158.21M(-13.8%)
DateAnnualQuarterlyTTM
Jun 2022
-
-$33.37M(-32.8%)
-$183.43M(-3.9%)
Mar 2022
-
-$49.65M(-0.1%)
-$190.83M(+10.1%)
Dec 2021
-$173.27M(+302.9%)
-$49.72M(-1.9%)
-$173.27M(+22.1%)
Sep 2021
-
-$50.68M(+24.3%)
-$141.91M(+33.5%)
Jun 2021
-
-$40.77M(+27.1%)
-$106.27M(+52.9%)
Mar 2021
-
-$32.09M(+74.7%)
-$69.51M(+61.6%)
Dec 2020
-$43.00M
-
-
Dec 2020
-
-$18.37M(+22.1%)
-$43.00M(+67.0%)
Sep 2020
-
-$15.04M(+275.1%)
-$25.75M(+140.5%)
Jun 2020
-
-$4.01M(-28.2%)
-$10.71M(+59.9%)
Mar 2020
-
-$5.58M(+400.8%)
-$6.70M(+500.8%)
Dec 2019
-
-$1.11M
-$1.11M

FAQ

  • What is Taysha Gene Therapies annual operating income?
  • What is the all time high annual operating profit for Taysha Gene Therapies?
  • What is Taysha Gene Therapies annual operating profit year-on-year change?
  • What is Taysha Gene Therapies quarterly operating income?
  • What is the all time high quarterly operating profit for Taysha Gene Therapies?
  • What is Taysha Gene Therapies quarterly operating profit year-on-year change?
  • What is Taysha Gene Therapies TTM operating income?
  • What is the all time high TTM operating profit for Taysha Gene Therapies?
  • What is Taysha Gene Therapies TTM operating profit year-on-year change?

What is Taysha Gene Therapies annual operating income?

The current annual operating profit of TSHA is -$86.62M

What is the all time high annual operating profit for Taysha Gene Therapies?

Taysha Gene Therapies all-time high annual operating income is -$43.00M

What is Taysha Gene Therapies annual operating profit year-on-year change?

Over the past year, TSHA annual operating income has changed by -$15.25M (-21.36%)

What is Taysha Gene Therapies quarterly operating income?

The current quarterly operating profit of TSHA is -$21.42M

What is the all time high quarterly operating profit for Taysha Gene Therapies?

Taysha Gene Therapies all-time high quarterly operating income is -$1.11M

What is Taysha Gene Therapies quarterly operating profit year-on-year change?

Over the past year, TSHA quarterly operating income has changed by +$2.91M (+11.96%)

What is Taysha Gene Therapies TTM operating income?

The current TTM operating profit of TSHA is -$83.71M

What is the all time high TTM operating profit for Taysha Gene Therapies?

Taysha Gene Therapies all-time high TTM operating income is -$1.11M

What is Taysha Gene Therapies TTM operating profit year-on-year change?

Over the past year, TSHA TTM operating income has changed by -$4.57M (-5.77%)
On this page